Corporate
Jul. 6, 2013
Biotech sector sees an upswing in public offerings
Biotechnology and life sciences companies across the nation are seeing some of the most lucrative markets for initial public offerings in more than a decade, according to a new report.
Daily Journal Staff Writer
Biotechnology and life sciences companies across the nation are seeing some of the most lucrative markets for initial public offerings in more than a decade, according to a new report by Thomson Reuters and the National Venture Capital Association.
The report, issued earlier this week, indicates that 21 venture-backed companies raised a total of $2.1 billion in the public markets in the second qu...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In